These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 12744808)
1. Rationale for the use of cyclooxygenase-2-specific nonsteroidal anti-inflammatory drugs in ankylosing spondylitis: the available evidence. Köehler L; Kuipers JG; Zeidler H Curr Rheumatol Rep; 2003 Jun; 5(3):178-80. PubMed ID: 12744808 [No Abstract] [Full Text] [Related]
2. Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials. Hawk ET; Viner JL; Umar A Prog Exp Tumor Res; 2003; 37():210-42. PubMed ID: 12795057 [No Abstract] [Full Text] [Related]
3. Introduction. The role of COX-2-specific inhibitors in clinical practice. Lipsky PE Am J Med; 2001 Feb; 110 Suppl 3A():1S-2S. PubMed ID: 11173042 [No Abstract] [Full Text] [Related]
8. [Cyclo-oxygenase 2 inhibitors and cancer]. André T; Soria JC Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332 [No Abstract] [Full Text] [Related]
9. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications. Pascucci RA J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181 [TBL] [Abstract][Full Text] [Related]
10. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Feldman M; McMahon AT Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275 [No Abstract] [Full Text] [Related]
12. Cyclooxygenase-2: a therapeutic target. Turini ME; DuBois RN Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462 [TBL] [Abstract][Full Text] [Related]
13. Recommendations for the clinical use of cyclooxygenase-2-specific inhibitors. Lipsky PE Am J Med; 2001 Feb; 110 Suppl 3A():3S-5S. PubMed ID: 11173043 [No Abstract] [Full Text] [Related]
14. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application]. He W; Liu CF; Huang CQ Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825 [TBL] [Abstract][Full Text] [Related]
16. [A new class of nonsteroidal anti-inflammatory agents: COXIBs]. Costantino S Clin Ter; 2003; 154(1):5-6. PubMed ID: 12854276 [No Abstract] [Full Text] [Related]
17. Are the biologic and clinical effects of the COX-2-specific inhibitors an advance compared with the effects of traditional NSAIDs? Simon LS Curr Opin Rheumatol; 2000 May; 12(3):163-70. PubMed ID: 10803743 [TBL] [Abstract][Full Text] [Related]